The Mechanism and Latest Research Progress of Blood-Brain Barrier Breakthrough

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2024 Oct 26

PMID 39457617

Authors

Fei Wang

Liujie Qi

Zhongna Zhang

Huimin Duan

Yanchao Wang

Kun Zhang

Jingan Li

Affiliations

Soon will be listed here.

Abstract

The bloodstream and the central nervous system (CNS) are separated by the blood-brain barrier (BBB), an intricate network of blood vessels. Its main role is to regulate the environment within the brain. The primary obstacle for drugs to enter the CNS is the low permeability of the BBB, presenting a significant hurdle in treating brain disorders. In recent years, significant advancements have been made in researching methods to breach the BBB. However, understanding how to penetrate the BBB is essential for researching drug delivery techniques. Therefore, this article reviews the methods and mechanisms for breaking through the BBB, as well as the current research progress on this mechanism.

References

Ross A, Mc Nulty D, ODwyer C, Grabrucker A, Cronin P, Mulvihill J . Standardization of research methods employed in assessing the interaction between metallic-based nanoparticles and the blood-brain barrier: Present and future perspectives. J Control Release. 2019; 296:202-224. DOI: 10.1016/j.jconrel.2019.01.022. View

Yang M, Liu Y, Yu Y, Gong B, Ruan J, Fan H . Application of targeted liposomes-based salvianolic acid A for the treatment of ischemic stroke. Neurotherapeutics. 2024; 21(3):e00342. PMC: 11070274. DOI: 10.1016/j.neurot.2024.e00342. View

Shen X, Cui Z, Wei Y, Huo Y, Yu D, Zhang X . Exploring the potential to enhance drug distribution in the brain subregion via intranasal delivery of nanoemulsion in combination with borneol as a guider. Asian J Pharm Sci. 2023; 18(6):100778. PMC: 10711392. DOI: 10.1016/j.ajps.2023.100778. View

He Q, Liu J, Liang J, Liu X, Li W, Liu Z . Towards Improvements for Penetrating the Blood-Brain Barrier-Recent Progress from a Material and Pharmaceutical Perspective. Cells. 2018; 7(4). PMC: 5946101. DOI: 10.3390/cells7040024. View

Meresse S, Delbart C, Fruchart J, Cecchelli R . Low-density lipoprotein receptor on endothelium of brain capillaries. J Neurochem. 1989; 53(2):340-5. DOI: 10.1111/j.1471-4159.1989.tb07340.x. View

Zhang E, Knipp G, Ekins S, Swaan P . Structural biology and function of solute transporters: implications for identifying and designing substrates. Drug Metab Rev. 2002; 34(4):709-50. DOI: 10.1081/dmr-120015692. View

Furtado D, Bjornmalm M, Ayton S, Bush A, Kempe K, Caruso F . Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases. Adv Mater. 2018; 30(46):e1801362. DOI: 10.1002/adma.201801362. View

Zhang P, Cao F, Zhang J, Tan Y, Yao S . Temozolomide and chloroquine co-loaded mesoporous silica nanoparticles are effective against glioma. Heliyon. 2023; 9(8):e18490. PMC: 10412909. DOI: 10.1016/j.heliyon.2023.e18490. View

Peng Z, Li S, Han X, Al-Youbi A, Bashammakh A, El-Shahawi M . Determination of the composition, encapsulation efficiency and loading capacity in protein drug delivery systems using circular dichroism spectroscopy. Anal Chim Acta. 2016; 937:113-8. DOI: 10.1016/j.aca.2016.08.014. View

10.

Ranjan Patra C, Bhattacharya R, Mukhopadhyay D, Mukherjee P . Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev. 2009; 62(3):346-61. PMC: 2827658. DOI: 10.1016/j.addr.2009.11.007. View

11.

Dias M, Mapunda J, Vladymyrov M, Engelhardt B . Structure and Junctional Complexes of Endothelial, Epithelial and Glial Brain Barriers. Int J Mol Sci. 2019; 20(21). PMC: 6862204. DOI: 10.3390/ijms20215372. View

12.

Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U . Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. 2001; 109 Suppl 4:547-51. PMC: 1240579. DOI: 10.1289/ehp.01109s4547. View

13.

Aird W . Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res. 2007; 100(2):158-73. DOI: 10.1161/01.RES.0000255691.76142.4a. View

14.

Erickson M, Banks W . Transcellular routes of blood-brain barrier disruption. Exp Biol Med (Maywood). 2022; 247(9):788-796. PMC: 9134765. DOI: 10.1177/15353702221080745. View

15.

Pardridge W . Blood-brain barrier delivery. Drug Discov Today. 2007; 12(1-2):54-61. DOI: 10.1016/j.drudis.2006.10.013. View

16.

Arrieta V, Gould A, Kim K, Habashy K, Dmello C, Vazquez-Cervantes G . Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas. Nat Commun. 2024; 15(1):4698. PMC: 11156895. DOI: 10.1038/s41467-024-48326-w. View

17.

Tsou Y, Zhang X, Zhu H, Syed S, Xu X . Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials. Small. 2017; 13(43). DOI: 10.1002/smll.201701921. View

18.

Gaillard P, Visser C, de Boer A . Targeted delivery across the blood-brain barrier. Expert Opin Drug Deliv. 2005; 2(2):299-309. DOI: 10.1517/17425247.2.2.299. View

19.

Kirbas Cilingir E, Seven E, Zhou Y, Walters B, Mintz K, Pandey R . Metformin derived carbon dots: Highly biocompatible fluorescent nanomaterials as mitochondrial targeting and blood-brain barrier penetrating biomarkers. J Colloid Interface Sci. 2021; 592:485-497. DOI: 10.1016/j.jcis.2021.02.058. View

20.

Dehouck B, Fenart L, Dehouck M, Pierce A, Torpier G, Cecchelli R . A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol. 1997; 138(4):877-89. PMC: 2138047. DOI: 10.1083/jcb.138.4.877. View